Upstart Golf Star Jovan Rebula Earns Sunshine Tour Card

HUNTSVILLE, Ala., Dec. 13, 2021 /PRNewswire/ — After a strong 10th place finish at the South African Open recently, Hometown Lenders-sponsored rising international golf sensation Jovan Rebula has earned his Sunshine Tour card. The South African Open is an event on the Sunshine Tour and…

World Health Organization and St. Jude Children’s Research Hospital to dramatically increase global access to childhood cancer medicines

GENEVA and MEMPHIS, Tenn., Dec. 13, 2021 /PRNewswire/ — The World Health Organization and St. Jude Children’s Research Hospital today announced plans to establish a platform that will dramatically increase access to childhood cancer medicines around the world. Experience the interactive…

CGTN: In America, paying taxes is optional if you’re a billionaire

BEIJING, Dec. 12, 2021 /PRNewswire/ — American billionaires have been paying tax on just a tiny fraction of their income, if any at all, at a rate much lower than the average person struggling to live paycheck to paycheck, according to a report published in June by the non-profit…

Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant

DURHAM, N.C. and BEIJING, Dec. 12, 2021 /PRNewswire/ — Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced…

RYB Education, Inc. Reports Third Quarter 2021 Financial Results

BEIJING, Dec. 12, 2021 /PRNewswire/ — RYB Education, Inc. (“RYB” or the “Company”) (NYSE: RYB), a leading early childhood education service provider in China, today announced its unaudited financial results for the third quarter of 2021. Third Quarter 2021 Operational and Financial…

RYB Education, Inc. Selects Friedman as its Independent Registered Public Accounting Firm

BEIJING, Dec. 12, 2021 /PRNewswire/ — RYB Education, Inc. (“RYB” or the “Company”) (NYSE: RYB), a leading early childhood education service provider in China, today announced that, effective as of December 10, 2021, the Company engaged Friedman LLP (“Friedman”) as the Company’s…

The 28th China International Advertising Festival opened in Xiamen

BEIJING, Dec. 12, 2021 /PRNewswire/ — Sponsored by the China Advertising Association and specially supported by the Xiamen Municipal People’s Government, the 28th China International Advertising Festival opened in Xiamen on December 11. Settled to be held in Xiamen for the second year,…

Los datos en fase III muestran que TIBSOVO® (comprimidos de ivosidenib) en combinación con azacitidina mejora significativamente la supervivencia sin acontecimientos y la supervivencia general en pacientes con leucemia mieloide aguda con mutación de IDH1 sin tratamiento previo

PARIS y BOSTON, 11 de diciembre de 2021 /PRNewswire/ — Servier, líder creciente en oncología con el compromiso de llevar el futuro a los pacientes a los que atendemos, ha anunciado hoy los datos en fase III del estudio global AGILE que demuestran que TIBSOVO® (comprimidos de ivosidenib)…

Les résultats de l’étude internationale de phase 3 AGILE montrent que TIBSOVO® (comprimés d’ivosidénib) en association avec l’azacitidine améliore significativement la survie sans événement et la survie globale chez les patients atteints de leucémie myéloïde aiguë (LMA) non traitée auparavant et porteurs d’une mutation IDH1

TIBSOVO, en association avec l’azacitidine comparé à l’association placebo plus azacitidine, a également démontré une amélioration significative du taux de rémission complète, du taux de rémission complète et rémission complète avec récupération hématologique partielle et du taux de…

Daten der Phase III zeigen: TIBSOVO® (Ivosidenib-Tabletten) in Kombination mit Azacitidin verbessert signifikant das ereignisfreie Überleben und das Gesamtüberleben bei Patienten mit zuvor unbehandelter IDH1-mutierter akuter myeloischer Leukämie

TIBSOVO in Kombination mit Azacitidin im Vergleich zu Placebo plus Azacitidin zeigte auch eine signifikante Verbesserung der vollständigen Remissionsrate, der vollständigen Remission und der vollständigen Remission mit partieller hämatologischer Erholungsrate und objektiver Ansprechrate….

« Previous PageNext Page »